Bluebird bio Reports Q3 2024 Earnings and Future Outlook
Bluebird bio Inc ( (BLUE) ) has released its Q3 earnings. Here is a breakdown of the information Bluebird bio Inc presented to its investors.
Q3 2024 bluebird bio Inc Earnings Call
Welcome to bluebird bio's third quarter 2024 results conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session.
Bluebird: Q3 Earnings Snapshot
SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Bluebird Bio Inc. (BLUE) on Thursday reported a loss of $60.8 million in its third quarter. On a per-share basis, the Somerville, Massachusetts-based company said it had a loss of 31 cents.
Creatd: Q3 Earnings Snapshot
Creatd: Q3 Earnings Snapshot
VolitionRX: Q3 Earnings Snapshot
VolitionRX Ltd. (VNRX) on
Cara: Q3 Earnings Snapshot
Cara Therapeutics Inc. (CARA)
Pieris Pharmaceuticals: Q3 Earnings Snapshot
Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of $2.19. This story was generated by Automated Insights ( using data from Zacks Investment Research.
Northern Dynasty: Q3 Earnings Snapshot
(NAK) on Thursday reported a loss of $3.4 million in its third quarter. On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 1 cent. This story was generated by Automated Insights ( using data from Zacks Investment Research.
Digimarc: Q3 Earnings Snapshot
Digimarc Corp. (DMRC) on Thursday reported a loss of $10.8 million in its third quarter. The Beaverton, Oregon-based company said it had a loss of 50 cents per share. Losses, adjusted
Bluebird bio says it needs cash to operate beyond March 2025
Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...
Business Insider21h
Bluebird Bio (BLUE) Receives a Hold from William Blair
William Blair analyst Sami Corwin reiterated a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed today at $0.36. Corwin covers the Healthcare sector, focusing ...
Zacks.com on MSN6d
After Plunging -22.76% in 4 Weeks, Here's Why the Trend Might Reverse for Bluebird (BLUE)
Bluebird Bio (BLUE) has been beaten down lately with too much selling pressure. While the stock has lost 22.8% over the past ...
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
SOMERVILLE, Mass., November 14, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...
bluebird bio (NASDAQ:BLUE) Coverage Initiated by Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research ...
Five things: Job cuts, high-paying tech jobs, 'bandsplaining,' and dim all the lights
Five things you need to know, including job cuts, high-paying tech jobs, "bandsplaining," and dim all the lights, sweet ...
Zacks.com on MSN23h
Bluebird Bio (BLUE) Reports Q3 Loss, Lags Revenue Estimates
Bluebird Bio (BLUE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.66 per share a year ago. These figures are ...
Exploring bluebird bio's Earnings Expectations
Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...
bovnews3d
bluebird bio Inc (BLUE) Stock: More Resilient Than It Appears
JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...